The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
gp130 at the nexus of inflammation, autoimmunity, and cancer
Open accessAbstract
Review highlights the function of the cytokine receptor gp130, specifically the diverse roles it plays in inflammation, autoimmunity, and cancer. Glycoprotein 130 (gp130) is a shared receptor utilized by several related cytokines, including IL-6, IL-11, IL-27, Leukemia Inhibitory Factor (LIF), Oncostatin M (OSM), Ciliary Neurotrophic Factor (CNTF), Cardiotrophin 1 (CT-1) and Cardiotrophin-like Cytokine (CLC). Gp130 plays critical roles during development and gp130-deficient mice are embryonically lethal. However, the best characterized facet of this receptor and its associated cytokines is the ability to promote or suppress inflammation. The aim of this review is to discuss the role of gp130 in promoting or preventing the development of autoimmunity and cancer, two processes that are associated with aberrant inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 2×
“Moreover, IL-6-deficient mice or mice lacking gp130 specifically on T cells are resistant to EAE induction, as they develop diminished Th17 responses and instead, generate a response dominated by CD4 FoxP3 Tregs [57, 107].”
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 2×
“eral studies have identified elevated levels of IL-6 and IL-17 in lesions from MS patients, and transfer of Th17 cells can exacerbate disease in animal models [61, 90, 91].”
BackgroundInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Zhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,848
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 1×
“Consistent with these observations, mice with mutations in gp130-mediated signaling and specifically, IL-6-deficient mice generate defective antibody responses [51, 66, 67].”
BackgroundLock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Bcl6 mediates the development of T follicular helper cells
Nurieva, R. I., Chung, Y., Martinez, G. J., Yang, X. O., Tanaka, S., Matskevitch, T. D., Wang, Y.-H., & Dong, C. (2009) · Science · doi:10.1126/science.1176676 · Cited by 1,506
Breitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., & Förster, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1545 · Cited by 1,464
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function
Schaerli, P., Willimann, K., Lang, A. B., Lipp, M., Loetscher, P., & Moser, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1553 · Cited by 1,261
Nurieva, R. I., Chung, Y., Hwang, D., Yang, X. O., Kang, H. S., Ma, L., Wang, Y.-H., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.009 · Cited by 1,205
O'Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Barbieri, G., Pellegrini, S., et al. (1994) · Science · doi:10.1126/science.8272873 · Cited by 979
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
Self-citationBollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946 · cited 1×
“sion in colitis-associated epithelial neoplasias [182–184].”
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 927
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., & Ghilardi, N. (2006) · Nature Immunology · doi:10.1038/ni1375 · Cited by 825
Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., et al. (1994) · Science · doi:10.1126/science.8272872 · Cited by 814 · cited 1×
“Under normal circumstances, the Janus kinases JAK1, JAK2, and tyrosine kinase 2 are constitutively associated with gp130, but receptor engagement leads to their phosphorylation and activation [17, 18].”
BackgroundHurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K., & Kishimoto, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.332 · Cited by 783
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J. M., O'Shea, J. J., & Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni1537 · Cited by 775
Self-citationIL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Jones, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3463 · Cited by 771
Kastelein, R. A., Hunter, C. A., & Cua, D. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104758 · Cited by 763
Self-citationHirota, H., Chen, J., Betz, U. A. K., Rajewsky, K., Gu, Y., Ross, J., Müller, W., & Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80729-1 · Cited by 656
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
Boulanger, M. J., Chow, D.-C., Brevnova, E. E., & Garcia, K. C. (2003) · Science · doi:10.1126/science.1083901 · Cited by 642
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 635
SOCS regulation of the JAK/STAT signalling pathway
Croker, B. A., Kiu, H., & Nicholson, S. E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.010 · Cited by 611
Suppression of allergic airway inflammation by helminth-induced regulatory T cells
Wilson, M. S., Taylor, M. D., Balic, A., Finney, C. A. M., Lamb, J. R., & Maizels, R. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042572 · Cited by 611
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
IgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809850105 · Cited by 508
Ansel, K. M., McHeyzer-Williams, L. J., Ngo, V. N., McHeyzer-Williams, M. G., & Cyster, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1123 · Cited by 494
The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection
Villarino, A., Hibbert, L., Lieberman, L., Wilson, E., Mak, T., Yoshida, H., Kastelein, R. A., Saris, C., & Hunter, C. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00300-5 · Cited by 484
Self-citationA new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.
Li, W., Nishimura, R., Kashishian, A., Batzer, A. G., Kim, W. J., Cooper, J. A., & Schlessinger, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.509 · Cited by 481
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477 · cited 1×
“Specifically, recent work demonstrated that 60% of IHCA are associated with inframe somatic mutations in gp130 [178].”
BackgroundInterleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., & Athanasou, N. A. (2003) · Bone · doi:10.1016/s8756-3282(02)00915-8 · Cited by 477
Tebbutt, N. C., Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F. J., Malki, S., Alderman, B. M., Grail, D., Hollande, F., et al. (2002) · Nature Medicine · doi:10.1038/nm763 · Cited by 474
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 440
SOCS3 regulates the plasticity of gp130 signaling
Lang, R., Pauleau, A.-L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J. N., Rutschman, R., & Murray, P. J. (2003) · Nature Immunology · doi:10.1038/ni932 · Cited by 439
Dienz, O., Eaton, S. M., Bond, J. P., Neveu, W., Moquin, D., Noubade, R., Briso, E. M., Charland, C., Leonard, W. J., Ciliberto, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081571 · Cited by 439
Soluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Odegard, J. M., Marks, B. R., DiPlacido, L. D., Poholek, A. C., Kono, D. H., Dong, C., Flavell, R. A., & Craft, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080840 · Cited by 418
Structural Biology of Shared Cytokine Receptors
Wang, X., Lupardus, P., LaPorte, S. L., & Garcia, K. C. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090616 · Cited by 408
Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C., & Schaper, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12848 · Cited by 388 · cited 2×
“1) [33, 35, 36].”
BackgroundSOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
He, B., You, L., Uematsu, K., Zang, K., Xu, Z., Lee, A. Y., Costello, J. F., McCormick, F., & Jablons, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232790100 · Cited by 380
Decreased FOXP3 levels in multiple sclerosis patients
Huan, J., Culbertson, N., Spencer, L., Bartholomew, R., Burrows, G. G., Chou, Y. K., Bourdette, D., Ziegler, S. F., Offner, H., & Vandenbark, A. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20522 · Cited by 369
Venken, K., Hellings, N., Thewissen, M., Somers, V., Hensen, K., Rummens, J., Medaer, R., Hupperts, R., & Stinissen, P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02690.x · Cited by 360
Kelly, M. N., Kolls, J. K., Happel, K., Schwartzman, J. D., Schwarzenberger, P., Combe, C., Moretto, M., & Khan, I. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.617-621.2005 · Cited by 351
Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless
Brown, S., Hu, N., & Hombrı́a, J. C.-G. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00524-3 · Cited by 350
Ernst, M., Najdovska, M., Grail, D., Lundgren-May, T., Buchert, M., Tye, H., Matthews, V. B., Armes, J., Bhathal, P. S., Hughes, N. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34944 · Cited by 350
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339
Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., & Yoshikawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208788 · Cited by 339
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Ishizu, T., Osoegawa, M., Mei, F.-J., Kikuchi, H., Tanaka, M., Takakura, Y., Minohara, M., Murai, H., Mihara, F., Taniwaki, T., et al. (2005) · Brain · doi:10.1093/brain/awh453 · Cited by 334
IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells
Diveu, C., McGeachy, M. J., Boniface, K., Stumhofer, J. S., Sathe, M., Joyce-Shaikh, B., Chen, Y., Tato, C. M., McClanahan, T. K., de Waal Malefyt, R., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801162 · Cited by 333
Self-citationIL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 333
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F., & Poli, V (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1345 · Cited by 313
Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
Acquiring signalling specificity from the cytokine receptor gp130
Ernst, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2003.11.003 · Cited by 299
Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
Knüpfer, H., & Preiss, R. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0818-8 · Cited by 291
Dalrymple, S. A., Lucian, L. A., Slattery, R., McNeil, T., Aud, D. M., Fuchino, S., Lee, F., & Murray, R. (1995) · Infection and Immunity · doi:10.1128/iai.63.6.2262-2268.1995 · Cited by 287
Takahashi-Tezuka, M., Yoshida, Y., Fukada, T., Ohtani, T., Yamanaka, Y., Nishida, K., Nakajima, K., Hibi, M., & Hirano, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4109 · Cited by 286
Saito, M., Yoshida, K., Hibi, M., Taga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.4066 · Cited by 282
Hölscher, C., Hölscher, A., Rückerl, D., Yoshimoto, T., Yoshida, H., Mak, T., Saris, C., & Ehlers, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3534 · Cited by 279
Hilton, D. J., Hilton, A. A., Raicevic, A., Rakar, S., Harrison-Smith, M., Gough, N. M., Begley, C. G., Metcalf, D., Nicola, N. A., & Willson, T. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06802.x · Cited by 277
Hamano, S., Himeno, K., Miyazaki, Y., Ishii, K., Yamanaka, A., Takeda, A., Zhang, M., Hisaeda, H., Mak, T. W., Yoshimura, A., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00298-x · Cited by 264
Mutational switch of an IL-6 response to an interferon-γ-like response
Costa-Pereira, A. P., Tininini, S., Strobl, B., Alonzi, T., Schlaak, J. F., Is'harc, H., Gesualdo, I., Newman, S. J., Kerr, I. M., & Poli, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122236099 · Cited by 264
Development and characterization of IL-21–producing CD4+ T cells
Suto, A., Kashiwakuma, D., Kagami, S.-I., Hirose, K., Watanabe, N., Yokote, K., Saito, Y., Nakayama, T., Grusby, M. J., Iwamoto, I., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072057 · Cited by 246
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Dissection of Signaling Cascades through gp130 In Vivo
Ohtani, T., Ishihara, K., Atsumi, T., Nishida, K., Kaneko, Y., Miyata, T., Itoh, S., Narimatsu, M., Maeda, H., Fukada, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80162-4 · Cited by 243
Ward, L. D., Howlett, G. J., Discolo, G., Yasukawa, K., Hammacher, A., Moritz, R. L., & Simpson, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31651-4 · Cited by 237
Okamoto, H., Yamamura, M., Morita, Y., Harada, S., Makino, H., & Ota, Z. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400614 · Cited by 233
Okuda, Y. (1998) · International Immunology · doi:10.1093/intimm/10.5.703 · Cited by 229
Ernst, M., Inglese, M., Waring, P., Campbell, I. K., Bao, S., Clay, F. J., Alexander, W. S., Wicks, I. P., Tarlinton, D. M., Novak, U., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.189 · Cited by 227
Atsumi, T., Ishihara, K., Kamimura, D., Ikushima, H., Ohtani, T., Hirota, S., Kobayashi, H., Park, S.-J., Saeki, Y., Kitamura, Y., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020619 · Cited by 225 · cited 1×
“Conversely, gp130 Y759 mutant mice, which have sustained signaling through gp130, develop autoimmune arthritis spontaneously, characterized by accumulation of activated T cells and myeloid cells, which is dependent on IL-6 and STAT3 [162, 163].”
BackgroundGeneral nature of the STAT3-activated anti-inflammatory response.
El Kasmi, K. C., Holst, J., Coffre, M., Mielke, L., de Pauw, A., Lhocine, N., Smith, A. M., Rutschman, R., Kaushal, D., Shen, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7880 · Cited by 225
IL-6 Promotes NK Cell Production of IL-17 during Toxoplasmosis
Passos, S. T., Silver, J. S., O’Hara, A. C., Sehy, D., Stumhofer, J. S., & Hunter, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901843 · Cited by 223
Self-citationSustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
Isomoto, H., Mott, J. L., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Haan, S., & Gores, G. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.037 · Cited by 219
Betz, U. A. K., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Rajewsky, K., & Müller, W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1955 · Cited by 218
New insights into the differentiation and function of T follicular helper cells
King, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2644 · Cited by 215
Matsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
Tang, W., Geba, G. P., Zheng, T., Ray, P., Homer, R. J., Kuhn, C., Flavell, R. A., & Elias, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119113 · Cited by 210
The Benefit/Risk Profile of TNF-Blocking Agents: Findings of a Consensus Panel
Hochberg, M. C., Lebwohl, M. G., Plevy, S. E., Hobbs, K. F., & Yocum, D. E. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2004.11.006 · Cited by 203
Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R., Leonard, W. J., Leo, O., & Andris, F. (2009) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 196
Systemic Inflammation and COPD
Walter, R. E., Wilk, J. B., Larson, M. G., Vasan, R. S., Keaney, J. F., Lipinska, I., O'Connor, G. T., & Benjamin, E. J. (2008) · Chest · doi:10.1378/chest.07-0058 · Cited by 192
IL-27 inhibits the development of regulatory T cells via STAT3
Huber, M., Steinwald, V., Guralnik, A., Brustle, A., Kleemann, P., Rosenplanter, C., Decker, T., & Lohoff, M. (2008) · International Immunology · doi:10.1093/intimm/dxm139 · Cited by 191
Sawa, S.-I., Kamimura, D., Jin, G.-H., Morikawa, H., Kamon, H., Nishihara, M., Ishihara, K., Murakami, M., & Hirano, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052187 · Cited by 176 · cited 1×
“Conversely, gp130 Y759 mutant mice, which have sustained signaling through gp130, develop autoimmune arthritis spontaneously, characterized by accumulation of activated T cells and myeloid cells, which is dependent on IL-6 and STAT3 [162, 163].”
BackgroundAdvances in understanding the anti-inflammatory properties of IL-27
Stumhofer, J. S., & Hunter, C. A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.011 · Cited by 172
Self-citationChen, H.-W., Chen, X., Oh, S.-W., Marinissen, M. J., Gutkind, J. S., & Hou, S. X. (2002) · Genes & Development · doi:10.1101/gad.955202 · Cited by 171
Ghiglione, C., Devergne, O., Georgenthum, E., Carballès, F., Médioni, C., Cerezo, D., & Noselli, S. (2002) · Development · doi:10.1242/dev.00116 · Cited by 166
Positive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation
Villarino, A. V., Larkin, J., Saris, C. J. M., Caton, A. J., Lucas, S., Wong, T., de Sauvage, F. J., & Hunter, C. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7684 · Cited by 166
Self-citationInterleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice
Mendel, I., Katz, A., Kozak, N., Ben‐Nun, A., & Revel, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1727::aid-immu1727>3.0.co;2-# · Cited by 162
Salcedo, R., Stauffer, J. K., Lincoln, E., Back, T. C., Hixon, J. A., Hahn, C., Shafer-Weaver, K., Malyguine, A., Kastelein, R., & Wigginton, J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7170 · Cited by 161
Interleukin 27 attenuates collagen-induced arthritis
Niedbała, W., Cai, B., Wei, X., Patakas, A., Leung, B. P. L., McInnes, I. B., & Liew, F. Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083360 · Cited by 153
Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice
Suzuki, Y., Rani, S., Liesenfeld, O., Kojima, T., Lim, S., Nguyen, T. A., Dalrymple, S., Murray, R., & Remington, J. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2339-2345.1997 · Cited by 150
Disturbed regulatory T cell homeostasis in multiple sclerosis
Venken, K., Hellings, N., Liblau, R., & Stinissen, P. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.003 · Cited by 150
Kuhn, C., Homer, R., Zhu, Z., Ward, N., Flavell, R. A., Geba, G. P., & Elias, J. A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.3.3690 · Cited by 147
IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens
Neveu, W. A., Allard, J. B., Dienz, O., Wargo, M. J., Ciliberto, G., Whittaker, L. A., & Rincón, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802923 · Cited by 144
Cloning and Characterization of a Novel Class I Cytokine Receptor
Sprecher, C. A., Grant, F. J., Baumgartner, J. W., Presnell, S., Schrader, S. K., Yamagiwa, T., Whitmore, T. E., O’Hara, P. J., & Foster, D. F. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8576 · Cited by 143
Pathological Role of IL-6 in the Experimental Allergic Bronchial Asthma in Mice
Doganci, A., Sauer, K., Karwot, R., & Finotto, S. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:257 · Cited by 142
Rosas, L. E., Satoskar, A. A., Roth, K. M., Keiser, T. L., Barbi, J. J., Hunter, C. A., de Sauvage, F. J., & Satoskar, A. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050013 · Cited by 139
Self-citationConcentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges, A., Gabay, C., Silacci, P., Novick, D., Roux-Lombard, P., Grau, G. E., Dayer, J. M., VISCHER, T. L., & Guerne, P. A. (1997) · PubMed · Cited by 134
Antiproliferative Activity of IL-27 on Melanoma
Yoshimoto, T., Morishima, N., Mizoguchi, I., Shimizu, M., Nagai, H., Oniki, S., Oka, M., Nishigori, C., & Mizuguchi, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6527 · Cited by 129
Chen, Q., Wang, W., Bruce, R., Li, H., Schleider, D. M., Mulbury, M. J., Bain, M. D., Wallace, P. K., Baumann, H., & Evans, S. S. (2004) · Immunity · doi:10.1016/s1074-7613(03)00358-3 · Cited by 123
Nishimoto, N., Ogata, A., Shima, Y., Tani, Y., Ogawa, H., Nakagawa, M., Sugiyama, H., Yoshizaki, K., & Kishimoto, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1343 · Cited by 123
Differential Effects of IL-27 on Human B Cell Subsets
Larousserie, F., Charlot, P., Bardel, É., Froger, J., Kastelein, R. A., & Devergne, O. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5890 · Cited by 118
IL-6 induces hepatic inflammation and collagen synthesisin vivo
CHOI, I., KANG, H.-S., Yang, Y. M., & Pyun, K. H. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb07031.x · Cited by 116
Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice
Miyazaki, Y., Inoue, H., Matsumura, M., Matsumoto, K., Nakano, T., Tsuda, M., Hamano, S., Yoshimura, A., & Yoshida, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2401 · Cited by 115
Selvaraj, R. K., & Geiger, T. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2830 · Cited by 115
Langdon, C. M., Kerr, C. L., Hassen, M., Hara, T., Arsenault, A. L., & Richards, C. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64634-2 · Cited by 113
Endogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation
Wang, J., Homer, R., Chen, Q., & Elias, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4051 · Cited by 113
Richards, P. J., Nowell, M. A., Horiuchi, S., McLoughlin, R. M., Fielding, C. A., Grau, S., Yamamoto, N., Ehrmann, M., Rose‐John, S., Williams, A. S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21818 · Cited by 113
Matsui, M., Kishida, T., Nakano, H., Yoshimoto, K., Shin‐Ya, M., Shimada, T., Nakai, S., Imanishi, J., Yoshimoto, T., Hisa, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2793 · Cited by 112
Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B. S., Wingren, C., & Borrebaeck, C. A. K. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600170-mcp200 · Cited by 112
IL-6 promoter polymorphisms in rheumatoid arthritis
Pascual, M., Nieto, A., Matarán, L., Balsa, A., Pascual-Salcedo, D., & Martín, J. (2000) · Genes and Immunity · doi:10.1038/sj.gene.6363677 · Cited by 109
Usón, J., Balsa, A., Pascual‐Salcedo, D., Cabezas, J. A., Gonzalez-Tarrio, J., Martín-Mola, E., & Fontán, G. (1997) · PubMed · Cited by 106
Salcedo, R., Hixon, J. A., Stauffer, J. K., Jalah, R., Brooks, A. D., Khan, T. M., Dai, R., Scheetz, L., Lincoln, E., Back, T. C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800471 · Cited by 99
A protective role for IL‐6 during early infection with Toxoplasma gondii
JEBBARI, Roberts, C. W., Ferguson, D. J. P., Bluethmann, & Alexander, A. (1998) · Parasite Immunology · doi:10.1046/j.1365-3024.1998.00152.x · Cited by 99
Lewkowich, I. P., Lajoie, S., Clark, J. R., Herman, N. S., Sproles, A. A., & Wills-Karp, M. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003879 · Cited by 99
IL6 and CRPhaplotypes are associated with COPD risk and systemic inflammation: a case-control study
Yanbaeva, D. G., Dentener, M. A., Spruit, M. A., Houwing‐Duistermaat, J. J., Kotz, D., Passos, V. L., & Wouters, E. F. �. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-23 · Cited by 97
Rowan, A. D., Wang, H., Cawston, T. E., & Richards, C. D. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64330-1 · Cited by 86
Langdon, C. M., Leith, J., Richards, C. D., & Smith, F. R. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401207 · Cited by 83
Furukawa, M., Takaishi, H., Takito, J., Yoda, M., Sakai, S., Hikata, T., Hakozaki, A., Uchikawa, S., Matsumoto, M., Chiba, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802091 · Cited by 82
Eddahibi, S., Chaouat, A., Tu, L., CHOUAID, C., Weitzenblum, E., HOUSSET, B., Maître, B., & Adnot, S. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-038ms · Cited by 78
IL-27 Directly Restrains Lung Tumorigenicity by Suppressing Cyclooxygenase-2-Mediated Activities
Ho, M.-Y., Leu, S.-J. J., Sun, G.-H., Tao, M., Tang, S., & Sun, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901272 · Cited by 77
Ihn, H., & Tamaki, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2149 · Cited by 76
Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle
Ammit, A. J., Moir, L. M., Oliver, B. G. G., Hughes, J. M., Alkhouri, H., Ge, Q., Burgess, J. K., Black, J. L., & Roth, M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00230.2006 · Cited by 73
An anti‐inflammatory role for interleukin‐11 in established murine collagen‐induced arthritis
Walmsley, BUTLER, MARINOVA‐MUTAFCHIEVA, & Feldmann, M. (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00568.x · Cited by 70
Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation.
Betz, U. (1998) · International Immunology · doi:10.1093/intimm/10.8.1175 · Cited by 70
Zhu, S., Lee, D. A., & Li, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902371 · Cited by 68
Duncan, M. R., Hasan, A., & Berman, B. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613623 · Cited by 65
Shinozaki, Y., Wang, S., Miyazaki, Y., Miyazaki, K., Yamada, H., Yoshikai, Y., Hara, H., & Yoshida, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.24107 · Cited by 65
Huang, N., Liu, L., Wang, X., Liu, D., Yin, S., & Yang, X. (2008) · DNA and Cell Biology · doi:10.1089/dna.2007.0715 · Cited by 62
Howlett, M., Judd, L. M., Jenkins, B. J., Gruta, N. L. L., Grail, D., Ernst, M., & Giraud, A. S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.068 · Cited by 62
Qiu, Z., Fujimura, M., Kurashima, K., Nakao, S., & Mukaida, N. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02013.x · Cited by 61
Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1β
Faffe, D. S., Flynt, L., Mellema, M. S., Whitehead, T. R., Bourgeois, K., Panettieri, R. A., Silverman, E. S., & Shore, S. A. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00333.2004 · Cited by 56
Bamber, B. A., Reife, R. A., Haugen, H. S., & Clegg, C. H. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050191 · Cited by 53
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
Hu, P., Hu, H., Chen, M., Peng, M.-L., Tang, L. P., Tang, K., Matsui, M., Belladonna, M. L., Yoshimoto, T., Zhang, D., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.025 · Cited by 52
Loss of oncostatin M receptor β in metastatic melanoma cells
Lacreusette, A., Nguyen, J., Pandolfino, M., Khammari, A., Dréno, B., Jacques, Y., Godard, A., & Blanchard, F. (2006) · Oncogene · doi:10.1038/sj.onc.1209844 · Cited by 51
Oncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13
Faffe, D. S., Flynt, L., Mellema, M. S., Moore, P. E., Silverman, E. S., Subramaniam, V., Jones, M. R., Mizgerd, J. P., Whitehead, T. R., Imrich, A., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.033 · Cited by 51
Knight, D., Ernst, M., Anderson, G., Moodley, Y., & Mutsaers, S. (2003) · Pharmacology and Therapeutics · doi:10.1016/s0163-7258(03)00095-0 · Cited by 50
Hintzen, C., Quaiser, S., Pap, T., Heinrich, P. C., & Hermanns, H. M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24602 · Cited by 49
Sander, L. E., Obermeier, F., Dierssen, U., Kroy, D. C., Singh, A. K., Seidler, U. E., Streetz, K. L., Lutz, H. H., Müller, W., Tacke, F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3586 · Cited by 45
Fritz, D. K., Kerr, C. L., Li, T., Smyth, D. R., & Richards, C. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4352 · Cited by 44
Kumanogoh, A., Marukawa, S., Kumanogoh, T., Hirota, H., Yoshida, K., Lee, I.-S., Yasui, T., Yoshida, K., Taga, T., & Kishimoto, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2478 · Cited by 41
Fujita, H., Teng, A., Nozawa, R., Takamoto-Matsui, Y., Katagiri-Matsumura, H., Ikezawa, Z., & Ishii, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800520 · Cited by 35
Ying, M., Li, D., Yang, L., Wang, M., Wang, N., Chen, Y., He, M., & Wang, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0819-6 · Cited by 34
IL-27 induces the production of IgG1 by human B cells.
Boumendjel, A., Tawk, L., Malefyt, R. D. W., Boulay, V., Yssel, H., & Pène, J. (2006) · PubMed · Cited by 32
Sin, D. D., & Man, S. F. P. (2008) · Chest · doi:10.1378/chest.07-2085 · Cited by 25
ALTERED PULMONARY INTERLEUKIN-6 SIGNALING IN PRETERM INFANTS DEVELOPING BRONCHOPULMONARY DYSPLASIA
von Bismarck, P., Claaß, A., Schickor, C., Krause, M., & Rose‐John, S. (2008) · Experimental Lung Research · doi:10.1080/01902140802389693 · Cited by 25
Wang, X.-J., Taga, T., Yoshida, K., Saito, M., Kishimoto, T., & Kikutani, H. (1998) · Blood · doi:10.1182/blood.v91.9.3308 · Cited by 24
Paul, B., Mishra, V., Chaudhury, B., Awasthi, A., Das, A. B., Saxena, U., Saxena, A., Chauhan, L. K. S., Kumar, P., & Raisuddin, S. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000155740 · Cited by 22
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumors #
Spannbauer, M., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.22902 · Cited by 17
The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2
Cited by
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
The two faces of IL-6 in the tumor microenvironment
Fisher, D. T., Appenheimer, M. M., & Evans, S. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.008 · Cited by 693
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Wallerian degeneration: the innate-immune response to traumatic nerve injury
Rotshenker, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-109 · Cited by 510
The composition and signaling of the IL-35 receptor are unconventional
Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2227 · Cited by 450
Self-citation
Metadata
- Authors
- Silver, J. S., & Hunter, C. A.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-07
- Volume
- 88
- Issue
- 6
- Pages
- 1145-1156
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2032835141
- Cited by
- 254
- References
- 190
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.